IP Library › Granted Patent US 9,102,653
Granted Patent B2
US 9,102,653 · App. 14/322,165 · Granted Aug 11, 2015

Substituted quinazolinones as vanilloid antagonists

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,102,653
App. No.
14/322,165
Granted
Aug 11, 2015
Kind
B2
Abstract

The present specification relates to the use of a quinazolinone compound of the formula (I) wherein R 1 , R 2 , R 3 , R 4 , R 5 and m are as defined in the specification and in the claims, in free form or in salt form, and, where possible, in acid addition salt form.

Claims (3)

1. A method for treating eye pain in a mammal, comprising:

administering to a mammal in need thereof a therapeutically effective amount of a quinazolinone compound of the formula:

in free base form or in pharmaceutically acceptable acid addition salt form.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2023
From: NOVARTIS AG
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 065790/0208 →